---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-015888"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2023-04-03T23:59:59+00:00"
generated_at: "2026-06-17T06:54:10.974524+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SANUWAVE reports record FY2022 revenue of $16.7M, restates prior quarterly financials

## Summary
- FY2022 revenue $16.7M (+29% YoY); Q4 revenue $5.5M (+32% vs Q3 2022).
- GAAP operating loss improved to $9.0M in FY2022 from $14.1M in 2021; Q4 op loss $1.5M.
- Restated Q1, Q2, Q3 2022 financials due to material errors in accounting for shares, asset sales, vendor invoices, interest, inventory.
- Q1 2023 guidance: revenue growth 14-20% vs Q1 2022; supply constraint alleviated.
- New executives added (EVP Sales, VP Commercial Ops, VP Ops); stock now trades on OTCQB.

## SEC filing metadata
- accession: 0001140361-23-015888
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2023-04-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036123015888/0001140361-23-015888-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036123015888/brhc10050787_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-015888
- JSON: https://secwatch.observer/filing/0001140361-23-015888.json
- Plain text: https://secwatch.observer/filing/0001140361-23-015888.txt

## Key facts
- Earnings Releases
  SANUWAVE Health, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $5.5 million. Guidance initiated.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $5.5 million
  - Guidance: initiated
  - Result: reported results
  source text: Revenues increased by 32% to $5.5 million for the fourth quarter ended December 31, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000114036123015888/0001140361-23-015888-index.htm
- Earnings Releases
  SANUWAVE Health, Inc. reported the year ended December 31, 2022 results: revenue $16.7 million. Guidance initiated.
  - Period: the year ended December 31, 2022
  - Revenue: $16.7 million
  - Guidance: initiated
  - Result: reported results
  source text: Revenues increased by 29% to $16.7 million for the year ended December 31, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000114036123015888/0001140361-23-015888-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.